{"id":99174,"date":"2024-08-13T13:09:31","date_gmt":"2024-08-13T13:09:31","guid":{"rendered":"https:\/\/www.mymsd.ch\/it\/?page_id=99174"},"modified":"2026-09-30T08:03:30","modified_gmt":"2026-09-30T08:03:30","slug":"keytruda","status":"publish","type":"page","link":"https:\/\/www.mymsd.ch\/it\/succinctstatement\/keytruda\/","title":{"rendered":"Informazione professionale KEYTRUDA\u00ae"},"content":{"rendered":"\n<h1 class=\"wp-block-heading  has-border-color has-has-red-border-color-border-color has-teal-500-color has-text-color mhh-mcn-v1-heading--left mhh-mcn-v1-heading mhh-mcn-v1-heading--7f063d56cbd844dba0eea32b67e89606\">Informazione professionale breve di KEYTRUDA\u00ae (pembrolizumab)<\/h1>\n\n\n\n<p class=\"has-border-color has-has-red-border-color-border-color   mhh-mcn-v1-paragraph mhh-mcn-v1-paragraph--04fac1b115cffe18e56590be7a23a037 wp-block-paragraph\"><strong>KEYTRUDA<sup>\u00ae<\/sup>:<\/strong> <strong>PA: <\/strong>pembrolizumab. I: Adulti: monoterapia melanoma non resecabile o metastatico e trattamento adiuvante del melanoma in stadio III completamente resecato. Autorizzazione temporanea: monoterapia \u00e8 indicato nel trattamento adiuvante con melanoma allo stadio IIB o IIC completamente rimosso. P: KEYTRUDA\u00ae<br>soluzione per infusione \u00e8 destinato esclusivamente alla somministrazione endovenosa, non sottocutanea, verificare l\u2019etichetta; e.v. KEYTRUDA\u00ae non deve essere sostituito con KEYTRUDA\u00ae sottocutaneo (dosaggio diverso); \u00e8 possibile passare da e.v. KEYTRUDA\u00ae a KEYTRUDA\u00ae sottocutaneo e viceversa; adulti: 200 mg e.v. 30<br>min. ogni 3 settimane o 400 mg e.v. 30 min. ogni 6 settimane; trattamento fino a progressione della malattia o alla comparsa di recidiva, o fino a una tossicit\u00e0 inaccettabili; per la durata massima del trattamento in caso di adiuvante per melanoma 12 mesi. P<strong><em>er ulteriori indicazioni e i corrispondenti dosaggi per adulti e pazienti<br>pediatrici, si prega di fare riferimento all\u2019informazione professionale<\/em><\/strong>. <strong>CI<\/strong>: ipersensibilit\u00e0 a principio attivo\/sostanze ausiliarie. <strong>AP<\/strong>: reazioni avverse immuno-mediate: tra cui polmonite, colite, epatite, nefrite, endocrinopatie (incl. ipofisite, diabete di tipo 1, disfunzioni tiroidee; nel TNBC monitorare il livello di cortisolo), linfoistiocitosi emofagocitica (HLH), reazioni cutanee gravi (sindrome di Stevens-Johnson, necrolisi epidermica tossica, sindrome DRESS), altre reazioni avverse immuno-mediate; sindrome da sovrapposizione immuno-mediata di miocardite-miosite-miastenia gravis; pazienti con malattia autoimmune preesistente; trapianto \/ trapianto di cellule staminali (HSCT): malattia del trapianto contro l\u2019ospite (GvHD) e malattia veno-occlusiva epatica (VOD); terapia adiuvante per melanoma IIB\/IIC e NSCLC IB\/II\/IIIA: analisi dell\u2019OS in attesa; trattamento adiuvante dopo una terapia neoadiuvante associato a tossicit\u00e0 aggiuntiva; l\u2019effetto sulla successiva risomministrazione di terapie sistemiche a base di anti-PD-(L)1, comprese le resistenze in caso di recidiva, non \u00e8 stato studiato; enzimi epatici elevati se KEYTRUDA\u00ae viene associato ad axitinib (monitorare gli enzimi epatici prima dell\u2019inizio e durante il trattamento); infarto miocardico con l&#8217;associazione KEYTRUDA\u00ae + lenvatinib nell&#8217;RCC; mieloma multiplo: elevata mortalit\u00e0 nell&#8217;associazione di KEYTRUDA\u00ae con talidomide analogo e desametasone; associazione con trastuzumab nel carcinoma gastrico, consultare l&#8217;informazione professionale del trastuzumab; dati sulle terapie precedenti con immunoterapia per indicazioni individuali non disponibili, o tali pazienti esclusi dagli studi; reazioni correlate all&#8217;infusione (comprese ipersensibilit\u00e0 e anafilassi); pazienti sono stati esclusi dagli studi clinici (consultare l\u2019informazione professionale per dettagli); contiene polisorbato. <strong>IA<\/strong>: non note \/ non esaminato. <strong>G\/A<\/strong>: non raccomandato, contraccezione. <strong>EI<\/strong> (molto comune): infezioni delle vie respiratorie, infezione urinaria, anemia, neutropenia, trombocitopenia, ipotiroidismo, appetito ridotto, ipokaliemia, peso diminuito, ipomagnesiemia, insomnia, cefalea, neuropatia periferica, disgeusia, ipertensione, emorragie, dispnea, tosse, disfonia, diarrea, dolore addominale, nausea, vomito, stipsi, lipasi aumentata, infiammazioni orali, stomatite, ALT aumentata, AST aumentata,eruzione cutanea, eruzione maculo-papulare, prurito, alopecia, Sindrome da eritrodisestesia palmo-plantare, dolore muscolo-scheletrico, artralgia, miosite, dolore alle estremit\u00e0, proteinuria, creatinina ematica aumentata, stanchezza\/spossatezza, astenia, edema, febbre. <strong>Conf<\/strong>: 2 flaconcini perforabili da 100 mg \/ 4 ml.<strong> CD<\/strong>: A. TO: MSD Merck Sharp &amp; Dohme AG,B\u00fcrgenstrasse 8, 6005 Lucerna, Svizzera. (V31.0); CH-KEY-00084.<\/p>\n\n\n\n<p dir=\"ltr\" lang=\"it-IT\" class=\"has-border-color has-has-red-border-color-border-color   mhh-mcn-v1-paragraph mhh-mcn-v1-paragraph--04788e91f7d323a10ed2b6c9d2fb8e33 wp-block-paragraph\"><\/p>\n\n\n\n<p dir=\"ltr\" lang=\"it-IT\" class=\"has-border-color has-has-red-border-color-border-color   mhh-mcn-v1-paragraph mhh-mcn-v1-paragraph--04788e91f7d323a10ed2b6c9d2fb8e33 wp-block-paragraph\"><\/p>\n\n\n\n<hr class=\"wp-block-separator has-text-color has-gray-300-color has-alpha-channel-opacity has-gray-300-background-color has-background\" \/>\n\n\n\n<p dir=\"ltr\" lang=\"it-IT\" class=\"has-border-color has-has-red-border-color-border-color has-object-object-font-size   mhh-mcn-v1-paragraph mhh-mcn-v1-paragraph--77dd0cbbeff13d6433e6c639b7386c03 wp-block-paragraph\"><em>Prima della prescrizione, consultare l\u2019informazione professionale completa, pubblicata sul sito web di Swissmedic&nbsp;<a href=\"https:\/\/www.swissmedicinfo-pro.ch\/ShowText.aspx?textType=FI&amp;lang=IT&amp;authNr=66231\" target=\"_blank\" rel=\"noreferrer noopener\">www.swissmedicinfo-pro.ch<\/a>.<\/em><\/p>\n\n\n\n<p dir=\"ltr\" lang=\"en-US\" class=\"has-border-color has-has-red-border-color-border-color   mhh-mcn-v1-paragraph mhh-mcn-v1-paragraph--ffc98c54841e8202101bc9207546c1a8 wp-block-paragraph\"><\/p>\n","protected":false},"excerpt":{"rendered":"<p>Informazione professionale breve di KEYTRUDA\u00ae (pembrolizumab) KEYTRUDA\u00ae: PA: pembrolizumab. I: Adulti: monoterapia melanoma non resecabile o metastatico e trattamento adiuvante [&hellip;]<\/p>\n","protected":false},"author":73173,"featured_media":0,"parent":99147,"menu_order":0,"comment_status":"closed","ping_status":"closed","template":"","meta":{"_mhh_sticky_footer_settings":{"entityId":0},"_mhh_sticky_footer_posts":"","_mhh_sticky_footer_expanded":false,"_mhh_mcn_text_direction":"","_mhh_mcn_language":"","_mhh_mcn_left_sidebar_settings":{"entityId":0},"_mhh_mcn_sidebar_settings":{"entityId":0},"mhh_mcn_side_navigation_style":{"fontSize":{"l":"","m":"","s":""},"lineHeight":{"l":1.5,"m":1.5,"s":1.5},"itemColor":"","hoverItemColor":"","currentItemColor":"","borderItemColor":"","backgroundItemHoverColor":"","themeColor":""},"_mhh_mcn_child_page_navigation":{"isActive":false,"isSticky":false},"hide_header":false,"show_top_bar":false,"hide_footer":false,"full_width_layout":false,"icon":null,"job_code":"","primary_tag":1129,"editor_notices":[],"mconnectHideShareThis":false,"footnotes":"","mconnectIsArchiveTemplate":false,"mconnectArchiveFiltersDisabled":false,"mconnectArchiveLockAllPresetFilters":false,"mconnectArchiveHidePageSubmenu":false,"mconnectArchiveShowParentPageOnly":false,"mconnectArchiveDefaultOrder":"DESC","mconnectArchiveDefaultOrderBy":"date","mconnectArchivePostsPerPage":12,"mconnectArchivePostTypes":[],"mconnectArchiveAllowFilterBy":["category","tx-content-type","tx-product","tx-pathology","tx-active-ingredient","tx-therapeutic-area"],"mconnectArchiveTaxonomyOrder":[],"mconnectArchiveFilterSorting":["active","is_keyword","is_date"],"mconnectArchiveContentItemStyle":{"showExcerpt":true,"showImage":true,"showIcon":false,"showPrimaryTag":true,"showBorder":false,"showDates":false,"showCta":true,"isCard":false,"hasBackground":false,"showMetadata":true},"mconnectArchiveLayout":{"type":"list","hasFeatured":false},"mconnectDynamicTaxonomyEntities":[],"mconnectArchiveTerms_category":[],"mconnectArchiveAllowTerms_category":[],"mconnectArchiveTerms_tx-content-type":[],"mconnectArchiveAllowTerms_tx-content-type":[],"mconnectArchiveTerms_tx-product":[],"mconnectArchiveAllowTerms_tx-product":[],"mconnectArchiveTerms_tx-pathology":[],"mconnectArchiveAllowTerms_tx-pathology":[],"mconnectArchiveTerms_tx-active-ingredient":[],"mconnectArchiveAllowTerms_tx-active-ingredient":[],"mconnectArchiveTerms_tx-therapeutic-area":[],"mconnectArchiveAllowTerms_tx-therapeutic-area":[],"mconnectArchiveAllowTerms_dynamic-taxonomy":[],"mconnectArchiveLegacyDefaultTermsApplied":false,"mconnectContentUpdatesPerPage":10,"mconnectContentUpdatesViewMoreUrl":"","mconnectContentUpdatesTerms_tx-content-type":[],"mconnectContentUpdatesTerms_tx-product":[],"mconnectContentUpdatesTerms_tx-pathology":[],"mconnectContentUpdatesTerms_tx-active-ingredient":[],"mconnectContentUpdatesTerms_tx-therapeutic-area":[],"sidebar_toogle":0,"sidebar_toogle_notification_warning":true,"sidebar_toogle_notification_alert":true,"content_expiration_sidebar_date":"","content_expiration_sidebar_expired_post_status":"","content_expiration_sidebar_redirection":""},"categories":[1128],"tags":[1129],"ga4_page_audience":[],"ga4_page_birn_id":[],"ga4_page_branding":[501],"ga4_page_businessunit":[507],"ga4_page_campaign":[],"ga4_page_content_purpose":[1072],"ga4_page_customer_journey_stage":[],"ga4_page_customer_specialty":[588],"ga4_page_experience":[],"ga4_page_indication":[],"ga4_page_material_intent":[713],"ga4_page_product":[902],"ga4_page_region":[946],"ga4_page_therapeuticarea":[982],"tx-therapeutic-area":[280],"tx-product":[270],"tx-pathology":[],"tx-content-type":[1130],"tx-active-ingredient":[],"access":[],"user_status":[],"user_role":[],"class_list":["post-99174","page","type-page","status-publish","hentry","category-kfi","tag-kfi"],"yoast_head":"<!-- This site is optimized with the Yoast SEO plugin v28.2 - https:\/\/yoast.com\/product\/yoast-seo-wordpress\/ -->\n<title>Informazione professionale KEYTRUDA\u00ae - MyMSD.ch IT<\/title>\n<meta name=\"robots\" content=\"noindex, nofollow\" \/>\n<meta property=\"og:locale\" content=\"it_IT\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"Informazione professionale KEYTRUDA\u00ae - MyMSD.ch IT\" \/>\n<meta property=\"og:description\" content=\"Informazione professionale breve di KEYTRUDA\u00ae (pembrolizumab) KEYTRUDA\u00ae: PA: pembrolizumab. I: Adulti: monoterapia melanoma non resecabile o metastatico e trattamento adiuvante [&hellip;]\" \/>\n<meta property=\"og:url\" content=\"https:\/\/www.mymsd.ch\/it\/succinctstatement\/keytruda\/\" \/>\n<meta property=\"og:site_name\" content=\"MyMSD.ch IT\" \/>\n<meta property=\"article:modified_time\" content=\"2026-09-30T08:03:30+00:00\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:label1\" content=\"Tempo di lettura stimato\" \/>\n\t<meta name=\"twitter:data1\" content=\"3 minuti\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\\\/\\\/schema.org\",\"@graph\":[{\"@type\":\"WebPage\",\"@id\":\"https:\\\/\\\/www.mymsd.ch\\\/it\\\/succinctstatement\\\/keytruda\\\/\",\"url\":\"https:\\\/\\\/www.mymsd.ch\\\/it\\\/succinctstatement\\\/keytruda\\\/\",\"name\":\"Informazione professionale KEYTRUDA\u00ae - MyMSD.ch IT\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/www.mymsd.ch\\\/it\\\/#website\"},\"datePublished\":\"2024-08-13T13:09:31+00:00\",\"dateModified\":\"2026-09-30T08:03:30+00:00\",\"breadcrumb\":{\"@id\":\"https:\\\/\\\/www.mymsd.ch\\\/it\\\/succinctstatement\\\/keytruda\\\/#breadcrumb\"},\"inLanguage\":\"it-IT\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\\\/\\\/www.mymsd.ch\\\/it\\\/succinctstatement\\\/keytruda\\\/\"]}]},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\\\/\\\/www.mymsd.ch\\\/it\\\/succinctstatement\\\/keytruda\\\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Home\",\"item\":\"https:\\\/\\\/www.mymsd.ch\\\/it\\\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"Product Succinct Statement\",\"item\":\"https:\\\/\\\/www.mymsd.ch\\\/it\\\/succinctstatement\\\/\"},{\"@type\":\"ListItem\",\"position\":3,\"name\":\"Informazione professionale KEYTRUDA\u00ae\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\\\/\\\/www.mymsd.ch\\\/it\\\/#website\",\"url\":\"https:\\\/\\\/www.mymsd.ch\\\/it\\\/\",\"name\":\"MyMSD.ch IT\",\"description\":\"\",\"publisher\":{\"@id\":\"https:\\\/\\\/www.mymsd.ch\\\/it\\\/#organization\"},\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\\\/\\\/www.mymsd.ch\\\/it\\\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"it-IT\"},{\"@type\":\"Organization\",\"@id\":\"https:\\\/\\\/www.mymsd.ch\\\/it\\\/#organization\",\"name\":\"MSD Switzerland\",\"url\":\"https:\\\/\\\/www.mymsd.ch\\\/it\\\/\",\"logo\":{\"@type\":\"ImageObject\",\"inLanguage\":\"it-IT\",\"@id\":\"https:\\\/\\\/www.mymsd.ch\\\/it\\\/#\\\/schema\\\/logo\\\/image\\\/\",\"url\":\"https:\\\/\\\/www.mymsd.ch\\\/it\\\/wp-content\\\/uploads\\\/sites\\\/47\\\/2026\\\/11\\\/MSD-Logo-square.png\",\"contentUrl\":\"https:\\\/\\\/www.mymsd.ch\\\/it\\\/wp-content\\\/uploads\\\/sites\\\/47\\\/2026\\\/11\\\/MSD-Logo-square.png\",\"width\":500,\"height\":500,\"caption\":\"MSD Switzerland\"},\"image\":{\"@id\":\"https:\\\/\\\/www.mymsd.ch\\\/it\\\/#\\\/schema\\\/logo\\\/image\\\/\"}}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"Informazione professionale KEYTRUDA\u00ae - MyMSD.ch IT","robots":{"index":"noindex","follow":"nofollow"},"og_locale":"it_IT","og_type":"article","og_title":"Informazione professionale KEYTRUDA\u00ae - MyMSD.ch IT","og_description":"Informazione professionale breve di KEYTRUDA\u00ae (pembrolizumab) KEYTRUDA\u00ae: PA: pembrolizumab. I: Adulti: monoterapia melanoma non resecabile o metastatico e trattamento adiuvante [&hellip;]","og_url":"https:\/\/www.mymsd.ch\/it\/succinctstatement\/keytruda\/","og_site_name":"MyMSD.ch IT","article_modified_time":"2026-09-30T08:03:30+00:00","twitter_card":"summary_large_image","twitter_misc":{"Tempo di lettura stimato":"3 minuti"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"WebPage","@id":"https:\/\/www.mymsd.ch\/it\/succinctstatement\/keytruda\/","url":"https:\/\/www.mymsd.ch\/it\/succinctstatement\/keytruda\/","name":"Informazione professionale KEYTRUDA\u00ae - MyMSD.ch IT","isPartOf":{"@id":"https:\/\/www.mymsd.ch\/it\/#website"},"datePublished":"2024-08-13T13:09:31+00:00","dateModified":"2026-09-30T08:03:30+00:00","breadcrumb":{"@id":"https:\/\/www.mymsd.ch\/it\/succinctstatement\/keytruda\/#breadcrumb"},"inLanguage":"it-IT","potentialAction":[{"@type":"ReadAction","target":["https:\/\/www.mymsd.ch\/it\/succinctstatement\/keytruda\/"]}]},{"@type":"BreadcrumbList","@id":"https:\/\/www.mymsd.ch\/it\/succinctstatement\/keytruda\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Home","item":"https:\/\/www.mymsd.ch\/it\/"},{"@type":"ListItem","position":2,"name":"Product Succinct Statement","item":"https:\/\/www.mymsd.ch\/it\/succinctstatement\/"},{"@type":"ListItem","position":3,"name":"Informazione professionale KEYTRUDA\u00ae"}]},{"@type":"WebSite","@id":"https:\/\/www.mymsd.ch\/it\/#website","url":"https:\/\/www.mymsd.ch\/it\/","name":"MyMSD.ch IT","description":"","publisher":{"@id":"https:\/\/www.mymsd.ch\/it\/#organization"},"potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/www.mymsd.ch\/it\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"it-IT"},{"@type":"Organization","@id":"https:\/\/www.mymsd.ch\/it\/#organization","name":"MSD Switzerland","url":"https:\/\/www.mymsd.ch\/it\/","logo":{"@type":"ImageObject","inLanguage":"it-IT","@id":"https:\/\/www.mymsd.ch\/it\/#\/schema\/logo\/image\/","url":"https:\/\/www.mymsd.ch\/it\/wp-content\/uploads\/sites\/47\/2026\/11\/MSD-Logo-square.png","contentUrl":"https:\/\/www.mymsd.ch\/it\/wp-content\/uploads\/sites\/47\/2026\/11\/MSD-Logo-square.png","width":500,"height":500,"caption":"MSD Switzerland"},"image":{"@id":"https:\/\/www.mymsd.ch\/it\/#\/schema\/logo\/image\/"}}]}},"_links":{"self":[{"href":"https:\/\/www.mymsd.ch\/it\/wp-json\/wp\/v2\/pages\/99174","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/www.mymsd.ch\/it\/wp-json\/wp\/v2\/pages"}],"about":[{"href":"https:\/\/www.mymsd.ch\/it\/wp-json\/wp\/v2\/types\/page"}],"author":[{"embeddable":true,"href":"https:\/\/www.mymsd.ch\/it\/wp-json\/wp\/v2\/users\/73173"}],"replies":[{"embeddable":true,"href":"https:\/\/www.mymsd.ch\/it\/wp-json\/wp\/v2\/comments?post=99174"}],"version-history":[{"count":13,"href":"https:\/\/www.mymsd.ch\/it\/wp-json\/wp\/v2\/pages\/99174\/revisions"}],"predecessor-version":[{"id":106980,"href":"https:\/\/www.mymsd.ch\/it\/wp-json\/wp\/v2\/pages\/99174\/revisions\/106980"}],"up":[{"embeddable":true,"href":"https:\/\/www.mymsd.ch\/it\/wp-json\/wp\/v2\/pages\/99147"}],"wp:attachment":[{"href":"https:\/\/www.mymsd.ch\/it\/wp-json\/wp\/v2\/media?parent=99174"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/www.mymsd.ch\/it\/wp-json\/wp\/v2\/categories?post=99174"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/www.mymsd.ch\/it\/wp-json\/wp\/v2\/tags?post=99174"},{"taxonomy":"ga4_page_audience","embeddable":true,"href":"https:\/\/www.mymsd.ch\/it\/wp-json\/wp\/v2\/ga4_page_audience?post=99174"},{"taxonomy":"ga4_page_birn_id","embeddable":true,"href":"https:\/\/www.mymsd.ch\/it\/wp-json\/wp\/v2\/ga4_page_birn_id?post=99174"},{"taxonomy":"ga4_page_branding","embeddable":true,"href":"https:\/\/www.mymsd.ch\/it\/wp-json\/wp\/v2\/ga4_page_branding?post=99174"},{"taxonomy":"ga4_page_businessunit","embeddable":true,"href":"https:\/\/www.mymsd.ch\/it\/wp-json\/wp\/v2\/ga4_page_businessunit?post=99174"},{"taxonomy":"ga4_page_campaign","embeddable":true,"href":"https:\/\/www.mymsd.ch\/it\/wp-json\/wp\/v2\/ga4_page_campaign?post=99174"},{"taxonomy":"ga4_page_content_purpose","embeddable":true,"href":"https:\/\/www.mymsd.ch\/it\/wp-json\/wp\/v2\/ga4_page_content_purpose?post=99174"},{"taxonomy":"ga4_page_customer_journey_stage","embeddable":true,"href":"https:\/\/www.mymsd.ch\/it\/wp-json\/wp\/v2\/ga4_page_customer_journey_stage?post=99174"},{"taxonomy":"ga4_page_customer_specialty","embeddable":true,"href":"https:\/\/www.mymsd.ch\/it\/wp-json\/wp\/v2\/ga4_page_customer_specialty?post=99174"},{"taxonomy":"ga4_page_experience","embeddable":true,"href":"https:\/\/www.mymsd.ch\/it\/wp-json\/wp\/v2\/ga4_page_experience?post=99174"},{"taxonomy":"ga4_page_indication","embeddable":true,"href":"https:\/\/www.mymsd.ch\/it\/wp-json\/wp\/v2\/ga4_page_indication?post=99174"},{"taxonomy":"ga4_page_material_intent","embeddable":true,"href":"https:\/\/www.mymsd.ch\/it\/wp-json\/wp\/v2\/ga4_page_material_intent?post=99174"},{"taxonomy":"ga4_page_product","embeddable":true,"href":"https:\/\/www.mymsd.ch\/it\/wp-json\/wp\/v2\/ga4_page_product?post=99174"},{"taxonomy":"ga4_page_region","embeddable":true,"href":"https:\/\/www.mymsd.ch\/it\/wp-json\/wp\/v2\/ga4_page_region?post=99174"},{"taxonomy":"ga4_page_therapeuticarea","embeddable":true,"href":"https:\/\/www.mymsd.ch\/it\/wp-json\/wp\/v2\/ga4_page_therapeuticarea?post=99174"},{"taxonomy":"tx-therapeutic-area","embeddable":true,"href":"https:\/\/www.mymsd.ch\/it\/wp-json\/wp\/v2\/tx-therapeutic-area?post=99174"},{"taxonomy":"tx-product","embeddable":true,"href":"https:\/\/www.mymsd.ch\/it\/wp-json\/wp\/v2\/tx-product?post=99174"},{"taxonomy":"tx-pathology","embeddable":true,"href":"https:\/\/www.mymsd.ch\/it\/wp-json\/wp\/v2\/tx-pathology?post=99174"},{"taxonomy":"tx-content-type","embeddable":true,"href":"https:\/\/www.mymsd.ch\/it\/wp-json\/wp\/v2\/tx-content-type?post=99174"},{"taxonomy":"tx-active-ingredient","embeddable":true,"href":"https:\/\/www.mymsd.ch\/it\/wp-json\/wp\/v2\/tx-active-ingredient?post=99174"},{"taxonomy":"access","embeddable":true,"href":"https:\/\/www.mymsd.ch\/it\/wp-json\/wp\/v2\/access?post=99174"},{"taxonomy":"user_status","embeddable":true,"href":"https:\/\/www.mymsd.ch\/it\/wp-json\/wp\/v2\/user_status?post=99174"},{"taxonomy":"user_role","embeddable":true,"href":"https:\/\/www.mymsd.ch\/it\/wp-json\/wp\/v2\/user_role?post=99174"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}